Evidence map›Paper›PMID 37390127›Full record

ArticleAnalytical chemistry2023

Strategies to Improve Multi-enzyme Compatibility and Coordination in One-Pot SHERLOCK.

Hongzhao Li, Dominic M S Kielich, Guodong Liu, Greg Smith, Alexander Bello, James E Strong, Bradley S Pickering

Abstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Advances in nanozyme-assisted CRISPR diagnostic technology.Frontiers in bioengineering and biotechnology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Rapid detection ofFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongzhao LiNational Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg R3E 3M4, Manitoba, Canada.
Dominic M S KielichDepartment of Medical Microbiology and Infectious Diseases, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg R3E 0J9, Manitoba, Canada.
Guodong LiuNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg R3E 3M4, Manitoba, Canada.
Greg SmithNational Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg R3E 3M4, Manitoba, Canada.
Alexander BelloNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg R3E 3M4, Manitoba, Canada.
James E StrongDepartment of Medical Microbiology and Infectious Diseases, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg R3E 0J9, Manitoba, Canada.
Bradley S PickeringNational Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg R3E 3M4, Manitoba, Canada.ORCID 0000-0002-8613-5402

Funding

CIHR 202002OV1-440200-COV-CDAA-192840
6 · The paper itself

Abstract

While molecular diagnostics generally require heating elements that supply high temperatures such as 95 °C in polymerase chain reaction and 60-69 °C in loop-mediated isothermal amplification, the recently developed CRISPR-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can operate at 37 °C or a similar ambient temperature. This unique advantage may be translated into highly energy-efficient or equipment-free molecular diagnostic systems with unrestricted deployability. SHERLOCK is characterized by ultra-high sensitivity when performed in a traditional two-step format. For RNA sensing, the first step combines reverse transcription with recombinase polymerase amplification, while the second step consists of T7 transcription and CRISPR-Cas13a detection. The sensitivity drops dramatically, however, when all these components are combined into a single reaction mixture, and it largely remains an unmet need in the field to establish a high-performance one-pot SHERLOCK assay. An underlying challenge, conceivably, is the extremely complex nature of a one-pot formulation, crowding a large number of reaction types using at least eight enzymes/proteins. Although previous work has made substantial improvements by serving individual enzymes/reactions with accommodating conditions, we reason that the interactions among different enzymatic reactions could be another layer of complicating factors. In this study, we seek optimization strategies by which inter-enzymatic interference may be eliminated or reduced and cooperation created or enhanced. Several such strategies are identified for SARS-CoV-2 detection, each leading to a significantly improved reaction profile with faster and stronger signal amplification. Designed based on common molecular biology principles, these strategies are expected to be customizable and generalizable with various buffer conditions or pathogen types, thus holding broad applicability for integration into future development of one-pot diagnostics in the form of a highly coordinated multi-enzyme reaction system.

Indexed as

COVID-19SARS-CoV-2HumansNucleic Acid Amplification TechniquesReverse TranscriptionRNA, ViralSensitivity and SpecificityRNA, Viral

Identifiers

PMID37390127
PMCPMC10357406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.